METHOD OF LASER THERAPY OF PATIENTS WITH PSORIASIS Russian patent published in 2015 - IPC A61N5/67 

FIELD: medicine.

SUBSTANCE: method involves a session combining local laser irradiation covering 4 affected areas and intravenous laser blood irradiation (ILBI). The sessions are daily, during afternoon, during 15 days. The local exposure uses a matrix emitter consisting of 8 laser diodes of the total surface area of 8 cm². A wave length is 635 nm. The exposure length is 2 minutes per one area in the pulse contact mode. A light pulse length is 100-130 ns. A pulse power is 40 W at a varying frequency. The ILBI uses continuous laser light at a wave length of 525 nm with varying power and exposure. The exposure conforms to the following schedule: 1^st session - local: frequency 80 Hz, ILBI: power 2 mW, exposure 5 min. 2^nd session - local: frequency 150 Hz, ILBI: power 5 mW, exposure 7 min. 3^rd session - local: frequency 600 Hz, ILBI: power 5 mW, exposure 12 min. 4^th session - local: frequency 1,500 Hz, ILBI: power 10 mW, exposure 15 min. 5^th session - local: frequency 3,000 Hz, ILBI: power 15 mW, exposure 15 min. 6^th-7^th sessions - local: frequency 6,000 Hz, ILBI: power 15 mW, exposure 20 min. 8^th-10^th sessions - local: frequency 10,000 Hz, ILBI: power 20 mW, exposure 20 min. 11^th-12^th sessions - local: frequency 1,500 Hz, ILBI: power 20 mW, exposure 20 min. 13^th-15^th sessions - local: frequency 80 Hz, ILBI: power 20 mW, exposure 20 min.

EFFECT: reducing the length of psoriasis treatment, prolonging remission that is ensured by the integrated effect on different links of the disease process.

1 tbl